STOCK TITAN

iFabric Corp. Announces Launch of Aura Scrubs at U.S. National Mass Retailer

(Very Positive)
Tags

iFabric (OTCQX:IFABF) announced that its subsidiary Intelligent Fabric Technologies (North America) is launching Aura, a new performance medical scrub line, in cooperation with a leading U.S. national mass retailer. Aura will initially roll out to approximately 400 physical stores across the United States and the retailer’s e-commerce platform.

Aura scrubs integrate IFTNA’s PROTX2 antimicrobial and ecoPEL fluorine-free water-repellent textile technologies. According to iFabric, an IFTNA-sponsored clinical trial published in the Journal of Hospital Infection showed statistically-significant reductions in bacterial contamination on treated scrubs. This is the third major retailer to adopt IFTNA’s technology-enhanced scrub platform, with collaboration extending beyond technology supply to product development, branding, manufacturing, and retail execution.

Loading...
Loading translation...

Positive

  • Aura scrub launch in approximately 400 U.S. brick-and-mortar stores plus e-commerce
  • Third major retailer to adopt IFTNA’s technology-enhanced scrub platform
  • Clinical trial showed statistically-significant bacterial reduction on treated scrubs in real-world use
  • Retail partnership extends to product development, branding, manufacturing and execution

Negative

  • None.

News Explained

The July 13, 2026 launch expands IFTNA’s retail distribution through approximately 400 U.S. stores and e-commerce; broader expansion remains conditional.

iFabric’s wholly owned subsidiary, IFTNA, is launching Aura medical scrubs with a U.S. national mass retailer in approximately 400 stores and through the retailer’s e-commerce platform.

For iFabric, the disclosed structural consequence is a wider retail channel for IFTNA-developed medical apparel. Although the release calls Aura an additional nationwide retail program, it states that the current rollout covers approximately 400 stores and e-commerce, while expansion to more stores is subject to consumer adoption, retail performance, and retailer planning.

The release identifies this as the third major retailer to adopt IFTNA’s technology-enhanced scrub platform. IFTNA’s role extends beyond technology supply to product development, branding, manufacturing, and retail execution for the program.

News Market Reaction – IFABF

+9.48%
+9.48% Session close to close

In the Jul 13 session, IFABF gained 9.48%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
  • Third major retailer to adopt IFTNA's technology-enhanced scrub platform

  • New Brand Expands Commercial Reach of PROTX2® and ecoPEL™, the Company's Proprietary Antimicrobial and Durable Water Repellant Technologies

MARKHAM, ON / ACCESS Newswire / July 13, 2026 / iFabric Corp. ("iFabric" or the "Company") (TSX:IFA)(OTCQX:IFABF) is pleased to announce that its wholly owned subsidiary, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"), is launching Aura, a new performance medical apparel scrubs line developed, branded, and manufactured by IFTNA, in cooperation with a leading U.S. national mass retailer.

The Aura scrubs collection is launching in approximately 400 brick-and-mortar stores across the United States, together with availability on the retailer's well-established e-commerce platform. The Company believes the program has the potential for expansion across additional stores, subject to consumer adoption, retail performance, and ongoing retailer planning.

Aura scrubs integrate two of IFTNA's flagship textile technologies: PROTX2®, IFTNA's advanced antimicrobial technology, and ecoPEL, IFTNA's fluorine-free durable water-repellent technology. Together, these technologies are designed to deliver enhanced performance for healthcare professionals working in demanding clinical environments.

"This launch marks another important milestone in our mission to make clinically supported textile technologies more readily accessible to healthcare professionals," said Giancarlo Beevis, President and CEO of IFTNA. "Aura brings together comfort, fit, function, and our class-leading PROTX2® and ecoPEL technologies in a product platform designed for everyday clinical use and delivered through one of the most important retail channels in the United States," added Mr. Beevis.

An IFTNA-sponsored clinical trial demonstrated statistically-significant reductions in surface bacterial contamination on treated scrubs worn in real-world healthcare environments compared with untreated scrubs, as published in the peer-reviewed Journal of Hospital Infection and available online at:

https://www.journalofhospitalinfection.com/article/S0195-6701(25)00222-1/fulltext

By integrating PROTX2® and ecoPEL into Aura scrubs, IFTNA is bringing the benefits of its clinically-validated textile platform to a broader population of healthcare professionals through additional nationwide retail distribution.

"The clinical trial results were a defining moment for IFTNA because they demonstrated that our textile technologies can deliver measurable performance in real healthcare environments," continued Mr. Beevis. "With Aura, we are now translating those results into an additional highly-accessible retail program that can reach more healthcare workers where they shop, both in stores and online," said Mr. Beevis

The launch of Aura represents the third major retailer to adopt IFTNA's technology-enhanced scrub platform and to partner with IFTNA beyond technology supply, including product development, branding, manufacturing, and retail execution. The Company believes this validates IFTNA's ability to deliver a complete end-to-end solution for major retail partners seeking differentiated, performance-driven medical apparel.

"Aura is not just another scrub launch," continued Mr. Beevis. "It reflects the full scope of what IFTNA can bring to retail partners: proprietary technologies, clinically-proven performance, product design, sourcing, manufacturing, brand development, and execution at scale. While we will let the retailer's, shelves do the talking over the coming quarters, we believe we'll hit the bullseye with this expansion," concluded Mr. Beevis

The Aura scrub assortment is expected to be available through the retailer's initial 400-store rollout and on the retailer's e-commerce platform. See link below:
https://www.target.com/b/aura/-/N-q643le6kcfe

About Aura

Aura is a new medical apparel scrubs brand developed by IFTNA to combine modern styling, comfort, fit, and utility with IFTNA's proprietary performance textile technologies. The brand is designed to provide healthcare professionals with accessible, performance-driven scrubs for everyday clinical use.

About iFabric Corp.

iFabric Corp. (TSX: IFA; OTCQX: IFABF) develops, licenses, and commercializes innovative performance technologies for textiles and apparel. Through its Intelligent Fabric Technologies (North America) division, iFabric partners with global brands and retailers to deliver enhanced fabric functionality-ranging from antimicrobial technologies to moisture management and PFAS-free water repellency-across diverse end uses. The Company also operates Coconut Grove Intimates, a long-standing intimate apparel business that provides stable cash flow and supports the continued growth of its technology platform.

For more information, visit:

www.ifabriccorp.com.

About IFTNA

Intelligent Fabric Technologies (North America) Inc., a wholly owned subsidiary of iFabric Corp., engineers and supplies proprietary textile chemistries-including PROTX2®, ecoPEL™, and DryTX™-and provides end-to-end program capabilities spanning technology integration, product development, branding support, and manufacturing execution across consumer, medical, and industrial markets.

About PROTX2®

PROTX2® is an eco-friendly textile technology designed to provide antimicrobial and anti-odour protection. When applied, PROTX2® is engineered to deliver durable performance intended to last through the life of the garment.

About ecoPEL™

ecoPEL™ is a fluorine-free durable water repellent ("DWR") technology designed to help deliver water repellency while maintaining fabric comfort and breathability, and to support sustainability objectives by avoiding fluorinated chemistry.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding the scope and timing of the Aura launch, potential store expansion, market adoption, future distribution, anticipated product performance attributes, prospective sales results, and the Company's retail growth strategy. Forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially. iFabric undertakes no obligation to update forward-looking statements except as required by applicable law.

FOR FURTHER INFORMATION PLEASE CONTACT:

Hylton Karon, President & CEO
Tel: 647.297.9815
Email: hyltonk@ifabriccorp.com

Giancarlo Beevis, COO
Tel: 647.225.4426
Email: gc@ifabriccorp.com

Hilton Price, CFO
Tel: 647.465.6161
Email: hilton.price@rogers.com

Website: www.ifabriccorp.com

Neither the TSX Exchange nor its Regulation Services Provider, as that term is defined in the policies of the TSX Exchange, accepts responsibility for the adequacy or accuracy of this press release.

SOURCE: iFabric Corp



View the original press release on ACCESS Newswire

FAQ

What did iFabric (IFABF) announce about the Aura scrubs launch on July 13, 2026?

iFabric announced the launch of its Aura performance medical scrubs line with a leading U.S. national mass retailer. According to iFabric, Aura will initially be available in about 400 U.S. stores and on the retailer’s e-commerce platform, broadening access for healthcare professionals.

How many stores will carry Aura scrubs from iFabric (IFABF) in the initial rollout?

Aura scrubs are expected to launch in approximately 400 brick-and-mortar stores across the United States. According to iFabric, the assortment will also be available on the retailer’s established e-commerce platform, with potential future expansion subject to consumer adoption and retail performance.

What technologies are used in iFabric’s Aura medical scrubs, and why are they important for IFABF investors?

Aura scrubs integrate IFTNA’s PROTX2 antimicrobial and ecoPEL fluorine-free durable water-repellent technologies. According to iFabric, these proprietary platforms are designed to enhance fabric performance in clinical environments, potentially strengthening the company’s competitive position in performance medical apparel distribution.

What clinical evidence supports the performance of iFabric’s PROTX2 technology used in Aura scrubs (IFABF)?

An IFTNA-sponsored clinical trial reported statistically-significant reductions in surface bacterial contamination on treated scrubs versus untreated scrubs. According to iFabric, these results were published in the peer-reviewed Journal of Hospital Infection, supporting the clinical performance claims of its textile technology in real-world healthcare settings.

Why is the Aura scrub launch strategically important as the third major retailer for iFabric (IFABF)?

The Aura launch marks the third major retailer adopting IFTNA’s technology-enhanced scrub platform. According to iFabric, this partnership goes beyond technology supply to include product development, branding, manufacturing, and retail execution, highlighting its capability to deliver end-to-end solutions to large retailers.

Where can healthcare professionals buy Aura scrubs from iFabric (IFABF) in the United States?

Aura scrubs will be available at an unnamed leading U.S. national mass retailer in about 400 stores and online. According to iFabric, customers can access the assortment through the retailer’s e-commerce site, expanding reach to healthcare professionals nationwide.